Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : MOS1SIP
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Recipient : IAVI
Deal Size : Inapplicable
Deal Type : Inapplicable
Mosaic HIV-1 Envelope Trimer Immunogens Administered to People Living with HIV (PLWH) in Africa
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
June 07, 2024
Lead Product(s) : MOS1SIP
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Recipient : IAVI
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : 763SIP8
Therapeutic Area : Undisclosed
Study Phase : Phase I
Recipient : Fundació Clínic per a la Recerca Biomèdica
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
March 16, 2023
Lead Product(s) : 763SIP8
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Recipient : Fundació Clínic per a la Recerca Biomèdica
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Afolia
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Comparative Pharmacokinetics of AFOLIA and Gonal-f® After Single Subcutaneous Application
Details : Undisclosed
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
June 10, 2010
Lead Product(s) : Afolia
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable